NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens in New York State

NARMS 合作协议计划旨在加强纽约州零售食品样本的抗生素耐药性监测

• 批准号: 9768196
• 负责人: Kimberlee Musser
• 金额: $ 11.26万
• 依托单位: WADSWORTH CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-01 至 2020-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9768196
• 关键词: NARMS; Cooperative; Agreement; Program; Enhance

The New York State Department of Health (NYSDOH) Wadsworth Center (WC) public health laboratory is committed to protecting and improving the health of New Yorkers through laboratory testing analysis, investigations and research. The specific aim of this project will be to improve detection of, and surveillance for, antibiotic resistance for Salmonella and Campylobacter isolated from food products purchased from selected grocery stores. Objectives will be to: 1) collect and test samples for Salmonella and Campylobacter utilizing microbiological tests; 2) collect, analyze and exchange surveillance data on isolate identifications and provide serotyping analysis; 3) ship 100% of Salmonella and Campylobacter isolates attained from meat samples for additional testing to FDA; and 4) collaborate with FDA, Center for Veterinary Medicine (CVM), NARMS and state laboratory partners. Outcomes expected from this work include: 1) providing an increase in the total amount of Salmonella and Campylobacter isolates from retail meats that can be analyzed; 2) maintaining the ability to compare results to surveillance data and exchange information and test results; 3) providing an increase in the number of isolates of Campylobacter and Salmonella submitted to the FDA; and 4) increased collaboration and communication among partnering entities.

纽约州卫生部 (NYSDOH) 沃兹沃斯中心 (WC) 公共卫生实验室致力于保护和改善人类健康 纽约人通过实验室测试分析、调查研究。 该项目的具体目标是改善对以下情况的检测和监测： 从食品中分离出的沙门氏菌和弯曲杆菌的抗生素耐药性 从选定的杂货店购买。目标是：1）收集和测试 利用微生物测试检测沙门氏菌和弯曲杆菌样本； 2）收集， 分析和交换有关隔离标识的监测数据，并提供 血清分型分析； 3) 运送 100% 的沙门氏菌和弯曲杆菌分离株 从肉类样本中提取供 FDA 进行额外测试； 4) 与 FDA 合作， 兽医中心 (CVM)、NARMS 和国家实验室合作伙伴。 这项工作的预期成果包括：1）增加总量 从零售肉类中分离出的沙门氏菌和弯曲杆菌的数量 分析； 2) 保持将结果与监测数据进行比较的能力 交换信息和测试结果； 3）增加数量 向 FDA 提交弯曲杆菌和沙门氏菌分离株； 4) 增加 合作实体之间的协作和沟通。